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Ciliary Sulcus Ahmed Valve Implantation
Kun Moon, MD, Yu Cheol Kim, MD, Kwang Soo Kim, MD
Department of Ophthalmology, College of Medicine, Dongsan Medical Center, Keimyung University, Daegu, Korea
Purpose: Ahmed glaucoma valves were implanted into the ciliary sulcus of two patients diagnosed with 
neovascular glaucoma with favorable outcomes.  
Methods: The study patients presented to our hospital with ocular pain caused by increased intraocular 
pressure (IOP). A thorough history was taken, and an ophthalmic examination was performed.
Results: A 71-year-old male patient and a 57-year-old female patient visited our hospital for ocular pain and 
persistent, elevated IOP. Each were diagnosed with neovascular glaucoma and underwent an Ahmed 
glaucoma valve implantation to the sulcus. After surgery, the patients maintained stable IOPs without major 
complications.
Conclusions: The method of Ahmed glaucoma valve implantation into the ciliary sulcus could reduce 
complications caused by implantation to the anterior chamber. It is thought to be an efficient method for the 
maintenance of appropriate IOP after surgery.
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Ischemia in the posterior segment of eye can occur in 
patients with neovascular glaucoma, and diverse therapeutic 
methods have been developed to combat this problem.
1,2 It 
is known that by performing panretinal photocoagulation 
first, the synthesis of factors that induce new blood vessel 
growth in the posterior segment of eye is suppressed, and 
migration of these factors to the anterior segment of the eye 
is thus prevented, allowing for the regression of new blood 
vessels. The success rate of trabeculectomy and other general 
glaucoma surgeries varies widely, from approximately 10 to 
78%. Nonetheless, for neovascular glaucoma, the tendency to 
bleed is high, and therefore the success rate has been reported 
generally to be poor.
3-6
For refractory glaucoma patients with a poor surgical 
prognosis, implants have been widely used, particularly the 
recently developed Ahmed glaucoma valve implant (New 
World Medical, Inc. Rancho Cucamonga, California, USA), 
which has been reported to reduce the initial hypotony after 
surgery, among other related complications.
7-9
We implanted Ahmed glaucoma valves (New World 
Medical, Inc. Rancho Cucamonga, California, Model FP7) in 
the sulcus of two patients diagnosed with neovascular 
glaucoma. We were able to obtain satisfactory intraocular 
pressures (IOP) without major surgical complications. Since 
this method that has not been yet been reported in the 
literature, the cases are reported here with a review of the 
literature.
Case
Case 1.
A 71-year-old male with diabetes mellitus presented to our 
hospital with a chief complaint of left ocular pain that 
progressively worsened over the course of three months. One 
year ago, he underwent bilateral cataract extraction with 
intraocular lens (IOL) implantation. The patient had also been 
experiencing visual disturbances and had been treated with 
eye drops prior to transfer to our hospital.
At the initial examination, the best corrected visual acuity 
of the right eye was 0.7, and the best corrected visual acuity 
of the left eye was 0.3. The IOP of the right eye measured 
by  Goldmann applanation tonometry was 12 mmHg, and the 
left eye was 34 mmHg. On slit lamp examination of the left 
eye, new blood vessels on the iris surface and adhesion of 
the new blood vessels to the adjacent peripheral anterior 
synechiae were detected. Panretinal photocoagulation was 
performed on the left eye, and topical steroids and atropine, 
were administered. For IOP control, a topical beta-blocker 
(Calte
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Fig. 1. The tube is inserted through the ciliary sulcus.
Fig. 2. Postoperative finding show regression of iris 
neovascularization.
anhydrase inhibitor (Mezomin
Ⓡ, Keukdong Pharm Co, 
Korea) were administered. Nevertheless, the IOP of the left 
eye measured by the Goldmann applanation tonometry was 
40 mmHg. Hence, an Ahmed glaucoma valve implantation 
was performed.
The implantation was performed under retrobulbar 
anesthesia. In the middle of the superior rectus muscle and 
the lateral rectus muscle, the fornix conjunctiva was incised 
approximately 8 mm from the limbus. The conjunctiva and 
the tenon's capsule were dissected from the sclera, and a 
limbal-based scleral flap 4×4 mm in size was prepared. The 
Ahmed glaucoma valve was implanted to the site between the 
superior rectus muscle and the lateral rectus muscle and fixed 
to the sclera with 10-0 nylon. Prior to the implantation of the 
Ahmed glaucoma valve, a 1 cc balanced salt solution (BSS
Ⓡ, 
Alcon, USA) was administered through the Ahmed glaucoma 
valve using a 26 G cannula in order to confirm correct 
functioning. Approximately 2 mm of the silicon tube was 
implanted on the inside of the posterior chamber, and the end 
of tube was cut at 30° degrees. Using a 23 G needle, the 
posterior chamber was perforated through the sulcus, and the 
tube was implanted (Figure 1). We confirmed that the tube 
was implanted in the correct position through dilated pupil. 
The area of the exposed tube was covered with the scleral 
flap and fixed to the sclera with 10-0 nylon, and the tenon's 
capsule and the conjunctiva were sutured with 10-0 nylon. 
One week after surgery, the left eye visual acuity was 0.04, 
the IOP was 5 mmHg, and on examination of the fundus, 
choroidal detachment was observed. Nonetheless, visual 
acuity two weeks after surgery improved to 0.08. The IOP 
was 8 mmHg, and on examination of the fundus, choroidal 
detachment was improved. One month after surgery, visual 
acuity was 0.4 and IOP had increased to 26 mmHg; 
consequently, a topical carbonic anhydrase inhibitor (Cosopt
Ⓡ, 
MSD, USA) was administered. Two months after surgery, 
visual acuity improved to 0.5, with a stable IOP of 17 
mmHg. On slit lamp examination, regression of new vessels 
in the iris surface was seen.
Case 2.
A 58-year-old female presented to our hospital with a four 
month history of right ocular pain that had progressively 
worsened. Two years prior, she underwent cataract extraction 
with IOL implantation, and during the first year 
postoperatively, she received panretinal photocoagulation 
therapy. One year ago, she underwent a pars plana vitrectomy 
for proliferative diabetic retinopathy. The patient was 
diagnosed with diabetes 17 years ago, but otherwise did not 
have a significant past medical history.
At the initial examination, the best corrected visual acuity 
of the right eye was 0.08, and the left eye was 0.3. The IOP 
of the right eye was measured using the Goldmann 
applanation tonometry and was 35 mmHg; the left eye was 
14 mmHg. On slit lamp examination, new vessels on the iris 
surface were detected, and in the anterior chamber angle 
examination, new vessels had formed. Due to the continuous 
proliferation of the fibrovascular membrane, closure of the 
right anterior chamber angle was detected. Topical 
beta-blockers and topical carbonic anhydrase inhibitors 
(Cosopt
Ⓡ, MSD, USA) were continuously administered, and 
photocoagulation for new vessels in the anterior chamber was 
performed. However, the ocular pressure could not be 
controlled; hence, an Ahmed glaucoma valve implantation 
was performed.
Surgery was performed by the method identical to the 
Case 1. In this case, however, due to the small size of her 
pupil, we examined the location of tube by using a 
Hirschman iris hook (Bausch & Lomb, Inc. St. Louis, 
Missouri). Four months after surgery, a slightly elevated IOP 
level at 20-22 mmHg was maintained. Five months after 
surgery, the visual acuity of the right eye was 0.08, and the 
IOP of the right eye stabilized to 17 mmHg. On slit lamp 
examination, the result of the regression of new vessels in 
the iris surface was detected (Fig. 2). Ten months after 
surgery, during the patient's final visit to our outpatient clinic, 
her visual acuity had not improved, but she did not K Moon, et al. CILIARY SULCUS AHMED VALVE IMPLANTATION
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have hypotony, hyphema, choroidal detachment or other 
complications, and her IOP was well-maintained at 12-17 
mmHg.
Discussion 
Neovascular glaucoma is a disease in which new vessels 
are formed in the iris due to the ischemia of the posterior 
segment of eye. The new vessels cause the occlusion of the 
trabecular meshwork resulting in the elevation of IOP in 
patient with diabetic retinopathy, branched retinal vein 
occlusion, carotid artery disease, etc. IOP cannot be 
controlled readily by medical treatments, and the risk of 
hemorrhage with the conventional filtering surgery for 
glaucoma trabeculectomy is high. The anterior chamber is 
occluded due to the continuous proliferation of the 
fibrovascular membrane. The surgery's success rate is low 
because of excessive wound healing reaction.
3
In order to avoid these complications, the frequency of 
glaucoma drainage device implantation is on the rise. After 
first designed by Zorab,
10 glaucoma drainage devices have 
continuously improved in terms of concept, materials, and 
shapes. The Ahmed drainage device used in our experiment 
has a unilateral valve to prevent hypotony. Theoretically, the 
valve is open at the pressure between 8-10 mmHg, and in 
cases where the IOP is lower than that, the valve is closed 
and controls the flow of the aqueous humor. Therefore, the 
Ahmed drainage device is designed to prevent postsurgical 
hypotony.
7 The device used in our cases has a silicone body 
with a connected silicone tube. The inner diameter of the 
silicone tube was 0.305 mm, the outer diameter was 0.635 
mm, the surface area of the silicone body was 184 mm
2, the 
length was 16 mm, the width was 13 mm, and the thickness 
was 0.9 mm. The valve system used to prevent hypotony 
consisted of a thin silicone elastomer membrane.
The complications reported after the Ahmed glaucoma 
valve implantation are hypotony, anterior chamber collapse, 
choroidal detachment, hyphema, tube malposition, tube 
occlusion, and extraocular movement (EOM) limitation, etc. 
Kim et al
11 have reported that they performed Ahmed 
glaucoma valve implantation for six years, and in 114 eyes 
of 112 patients who were available for postoperative 
follow-up for at least six months. The patients' clinical course 
was examined and complications were noted. It was found 
that hyphema occurred in 14% of patients, which was the 
most prevalent complication. In addition, there was also 
choroidal detachment, development of a shallow anterior 
chamber caused by hypotony, tube occlusion, tube 
malposition, endophthalmitis, as well as other complications. 
In the cases where the Ahmed glaucoma valve was 
implanted in the anterior chamber, and in the cases involving 
peripheral anterior synechiae in the adjacent iris, iris dialysis 
can develop. In cases where the tube is malpositioned, the 
tip of the glaucoma valve may contact the cornea, which may 
induce corneal decompensation.
11-14 Hu et al
14 claimed that 
during the valve implantation perforation with a needle 
parallel to the iris is important while performing anterior 
chamber paracentesis. There are several reasons causing 
corneal decompensation. Corneal decompensation occurs 
when the aqueous humor of the corneal area located near the 
tube affects corneal endothelial cells. This can occur in cases 
when a patient rubs his/her eyes or blinks his/her eyes 
intensely, when technical damage caused by tube-cornea 
contingence, inflammation cause by tube-iris contingence, or 
because of a chronic foreign body reaction to the tube.
15,16
Methods of Ahmed glaucoma valve implantation can be 
classified according to the location of the drainage device 
tube, to implant the device in the anterior chamber or to 
implant the device into the vitreous; the former may induce 
tube malposition, iris injury, and anterior chamber angle 
injury, and the latter may reduce the injury in the cornea, the 
iris, and the anterior chamber angle. Also the shortcomings 
of the latter are that the procedure is useful only for the eyes 
that underwent a previous vitrectomy, and even so, the base 
of the vitreous must have been removed thoroughly.
Recently, an Ahmed glaucoma valve for implantation in 
the vitreous (Pars plana clip
TM) was also developed and used. 
The former is better known in most cases, but some studies 
involving the latter have been reported. Regarding 
implantation of the glaucoma drainage devices to the 
vitreous, Schlote et al
17 have reported that it was performed 
in nine patients (11 eyes), and that the success rate reached 
91% one year after surgery. In Korea, Kook et al
18 reported 
that in a refractory glaucoma patient, the combination of pars 
plana vitrectomy and the Ahmed glaucoma valve 
implantation can stabilize the IOP postoperatively.
In our cases, instead of the implantation to the anterior 
chamber, the drainage device was implanted to the posterior 
chamber through the sulcus, in two eyes, and favorable 
results with  appropriate postsurgical IOPs were obtained. In 
one eye, because of initial hypotony, choroidal detachment 
developed, but it improved without special treatments.
The concern regarding the method of the implantation of 
the Ahmed glaucoma valve in the anterior chamber is that 
it may induce corneal decompensation due to postsurgical 
tube malposition as well as induce iris injury. In addition, 
injury of the anterior chamber angle may result in hyphema. 
The method of implantation to the vitreous may reduce the 
injury to the cornea, the iris, and the anterior chamber angle; 
however, it can be performed only on the eyes that 
underwent vitrectomy previously, and the tube tip could be 
occluded by the vitreous unless the vitreous base has been 
removed completely. The advantage of the method of 
implantation of the Ahmed glaucoma valve to the posterior 
chamber through the sulcus as used in our cases are that it 
does not injure the cornea, the iris or the anterior chamber 
angle, and it can be performed even on eyes without previous 
vitrectomy. Especially, it is more useful for corneal 
transplanted eyes and when there are small number of corneal 
endothelial cells.Kor J Ophthalmol Vol.21, No.2, 2007
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However, it is difficult to assess the location of the tube 
during surgery, and the fact that the surgery could be 
performed on only pseudophakia or aphakia may be a 
shortcoming. In addition, due to the friction of the valve tube 
and the iris, iris pigment dispersion may develop. In one of 
our cases, even though pupil dilation was induced, the 
location of the tube could not be assessed. We confirmed the 
above results by using a Hirschman iris hook during surgery. 
It is thought that the location of the tube after surgery may 
be assessed more readily with the use of the the UBM 
(Ultrasound biomicroscopy), Carrillo et al
19 detected valve 
tube obstruction by using UBM on a patient who was 
experiencing high IOP for two weeks after the Ahmed 
glaucoma valve implantation. Research regarding the 
differences of corneal endothelial cells via Specular 
microscopy when the Ahmed glaucoma valve is inserted in 
the anterior chamber versus when it was inserted in the 
ciliary sulcus should be performed in the future.
In our cases, two eyes received Ahmed glaucoma valve 
implantation in the ciliary sulcus and demonstrated a 
favorable outcome without major complications.
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